Drug Trial Radar · NCT00031161
Prevention of Dichloroacetate Toxicity
Last checked: Nov 19, 2026Latest source record: Mar 25, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Planned (sponsor's estimate)
Start
Sep 2001
Primary completion
Not stated
Study completion Sep 2005
Sponsor
- Lead sponsor
- University of FloridaAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 27, 2002
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Masking
- Double
- Primary purpose
- Prevention
- Who can join
- All sexes, from 3 months, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to determine the safety of dichloroacetate (DCA) with a low-tyrosine diet given with or without nitisinone (NTBC) in children with chronic lactic acidosis (CLA).
Conditions
- Acidosis, Lactic
- Chronic Disease
Interventions
Nitisinone (NTBC)Drug
DichloroacetateDrug
Low-tyrosin dietBehavioral
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Florida
Gainesville, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.